NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > COVID-19 > New insight into immune-pathology in COVID-19 lungs

New insight into immune-pathology in COVID-19 lungs

9 November 2023 · Listed under COVID-19, Respiratory Medicine

A study by Oxford researchers has provided new insights into how immune cells interact in the lungs of patients with severe COVID-19. 

graphic illustrating the lungs
Shutterstock,com

In a damaged lung with a massive cell infiltrate, as seen with severe COVID-19 infection, it can be difficult to determine which cells are involved in causing lung injury. Understanding this provides a first step to identifying the cells or pathways that can be targeted therapeutically. 

The paper, published in Nature Communications, was the result of a collaboration between immunobiologists, clinician scientists, computer scientists and mathematicians. It demonstrates how mathematics, combined with immunobiology and clinical understanding, can be used to discover interactions and cellular networks which are otherwise impossible to see.

The team used a 35-antibody panel to provide a detailed immune landscape of lung biopsies from patients with fatal COVID-19 infection. Using a bespoke suite of mathematical tools, the authors uncovered a specific association between a highly inflammatory cluster of immature neutrophils, CD8 T-cells and regenerating lung stem cells in the most damaged areas of the lungs.

Neutrophils and T-cells are both types of immune cells. Neutrophils are part of the innate immune system and are among the first responders in the immune response. T cells, on the other hand, are part of the adaptive immune system, providing a more specific response to infection than the neutrophils.

Circulating immature neutrophils are unusual but are known to be increased in the blood of patients with severe COVID-19. This study provides the first evidence of their presence in the lungs of those with severe COVID-19, and specific interaction with CD8 T-cells and lung stem cells. This suggests a potential role for immature neutrophils in lung injury and the possibility that this interferes with the ability of the lung to regenerate after severe viral infections. 

 DSC3970.JPG

Lead author Professor Ling-Pei Ho (pictured left), who co-leads the NIHR Oxford Biomedical Research Centre’s (BRC) Respiratory Theme, said: “This paper has been a testament to team science. It was an exciting time to see cellular patterns revealed by mathematical applications, which fitted biologically.

“Our next task is to tackle the functional side of this observation – how do immature neutrophil and CD8 T cells interact and what do they do to stem cells? We will expand these studies to other severe viral infections like influenza and severe lung diseases like idiopathic pulmonary fibrosis. Eventually, we hope to use this new understanding to improve treatment for these patients.”

The authors provide an open-source computational pipeline called Spatial Omics Oxford Pipeline (SpOOx) and an enhanced version of a visual-analytical tool, Multi-Dimensional Viewer (MDV) software first developed at the University of Oxford’s Weatherall Institute of Molecular Medicine (WIMM), as a resource for spatial analysis.

← Longer-term organ abnormalities confirmed in some post-hospitalised COVID patients
COVID-19 vaccines found effective in reducing long COVID symptoms →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre